Our Mission
Our Members
Our Initiatives
Present your research
Connect with GSEV members
Get inspired
Doing EV research in Germany?
Here's how and why you should become a member
Dear GSEV members,
to ensure that the future of GSEV aligns more closely with the interests and preferences of all the members in the future, we need your help!
We kindly request you, to take a few minutes (max 5) to complete a survey that aims to capture your feedback and suggestions. The link to the survey is provided below and we request you to submit your response by May 31, 2023. Your input will be critically evaluated and shared after the survey is completed.
Your active participation is essential to shape GSEV for your needs.
Please feel free to forward this link to colleagues who are not GSEV members but are also interested in EV research.
We are one of 13 professional societies which signed the recent press release, representing 55.000 academic and professional scientists from natural and life sciences. Below you can find the official statement alongside the proposal for the amandment of the WissZeitVG which has been published by the Federal Ministry for Research and Education (BMBF)
European EV Mobility Fellowship - call for applications
RE-LAUNCH of the EV Mobility programme MOVE!
We relaunch our first “International Mobility Fellowships” to foster collaborations among members of these Societies. The fellowship (up to 2000 €) should cover travel and accommodation expenses for a one-month stay of an Early Career Researcher (ECR; i.e. Ph.D. students or Postdoctoral fellows with less than five years´ experience pertaining to at least one of our Societies) in a different country of the host laboratory.
Board member and EV researcher Gregor Fuhrmann has evaluated the potential side effects of nanolipid-based COVID-19 vaccine at "Tagesschau Faktenfinder" - more infos here
ISEV and ISCT statement on EVs from MSCs and other cells:
considerations for potential therapeutic agents to suppress COVID-19 - more infos here
FDA notification on exosome products - more infos here
The US Food and Drug Administration has published an important statement on the use of non-approved exosome formulations in the clinics. Read more in our news section.
Graduate School on Tumour Secretome
The German Research Foundation has approved a new Graduate School on Tumour Sectretome. Speaker of this Excellence Initiative is Elke Pogge von Strandmann who is also member of the GSEV Board. Congratulations for this achievement!
The new MISEV 2018 - minimal information for studies on EVs are now published. Please have a look.
Druckversion